Definition:

Nephroblastoma, also known as Wilms tumor, is a rare type of kidney cancer that primarily affects children. It is a malignant tumor that originates in the cells of the embryonic kidneys – the organs responsible for filtering waste and excess fluids from the blood and producing urine. Nephroblastoma is named after Dr. Max Wilms, who first described the tumor in 1899.

Characteristics:

Nephroblastoma typically presents as a solid mass or tumor in one or both kidneys. It is usually encapsulated, meaning it is contained within a fibrous capsule, and can range in size from a small palpable lump to a large growth that occupies most of the kidney. Nephroblastoma is known for its potential to spread (metastasize) to other organs such as the lungs, liver, or lymph nodes.

Symptoms:

The signs and symptoms of nephroblastoma may vary depending on the size and location of the tumor. Some common symptoms include:

• Abdominal swelling or mass that can be felt
• Abdominal pain or discomfort
• Blood in the urine
• High blood pressure
• Fever
• Weight loss
• Anemia

Causes:

The precise cause of nephroblastoma is not yet fully understood. However, some genetic and environmental factors are believed to contribute to the development of this tumor. Certain genetic mutations or abnormalities that affect the genes involved in kidney development are thought to increase the risk. Additionally, some syndromes, such as WAGR syndrome and Denys-Drash syndrome, have been associated with a higher likelihood of developing nephroblastoma.

Treatment:

Treatment for nephroblastoma typically involves a combination of surgery, chemotherapy, and sometimes radiation therapy. The specific treatment plan may vary depending on the stage of the tumor and the overall health of the child. Surgery is often the first step to remove the tumor along with the affected kidney. Chemotherapy is then administered to destroy any remaining cancer cells, and radiation therapy may be utilized to target any metastatic sites.

Prognosis:

The prognosis for nephroblastoma has significantly improved over the years, thanks to advances in medical treatments. The survival rate for children with nephroblastoma is generally high, with approximately 90% of patients achieving long-term survival. Early diagnosis and prompt initiation of treatment play crucial roles in improving the prognosis. Regular follow-up care and monitoring are necessary to evaluate the child’s response to treatment and detect any potential recurrence or long-term complications.